KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $500,061 | +40.5% | 42,450 | +41.5% | 0.00% | – |
| Q1 2024 | $355,919 | -3.2% | 30,010 | 0.0% | 0.00% | – |
| Q4 2023 | $367,623 | +17.8% | 30,010 | -7.4% | 0.00% | – |
| Q3 2023 | $312,108 | +7.0% | 32,410 | 0.0% | 0.00% | – |
| Q2 2023 | $291,690 | +44.4% | 32,410 | +26.1% | 0.00% | – |
| Q1 2023 | $202,002 | +16.3% | 25,700 | 0.0% | 0.00% | – |
| Q4 2022 | $173,732 | -29.9% | 25,700 | +50.6% | 0.00% | – |
| Q3 2022 | $248,000 | +66.4% | 17,064 | +13.0% | 0.00% | – |
| Q2 2022 | $149,000 | -2.6% | 15,100 | +45.2% | 0.00% | – |
| Q1 2022 | $153,000 | -5.0% | 10,400 | -14.8% | 0.00% | – |
| Q4 2021 | $161,000 | -24.4% | 12,200 | 0.0% | 0.00% | – |
| Q3 2021 | $213,000 | -27.1% | 12,200 | 0.0% | 0.00% | – |
| Q2 2021 | $292,000 | -18.2% | 12,200 | -35.1% | 0.00% | – |
| Q4 2020 | $357,000 | +44.0% | 18,800 | -4.6% | 0.00% | – |
| Q3 2020 | $248,000 | +4.2% | 19,700 | 0.0% | 0.00% | – |
| Q2 2020 | $238,000 | +153.2% | 19,700 | +60.2% | 0.00% | – |
| Q1 2020 | $94,000 | -47.8% | 12,300 | +21.8% | 0.00% | – |
| Q4 2019 | $180,000 | +53.8% | 10,100 | 0.0% | 0.00% | – |
| Q3 2019 | $117,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $13,155,000 | 11.03% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $2,974,000 | 3.14% |
| Vivo Capital, LLC | 1,476,796 | $11,297,000 | 1.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 227,433 | $1,731,000 | 0.79% |
| DAFNA Capital Management LLC | 234,952 | $1,797,000 | 0.75% |
| Samsara BioCapital, LLC | 168,174 | $1,287,000 | 0.74% |
| Ghost Tree Capital, LLC | 350,000 | $2,678,000 | 0.71% |
| Ikarian Capital, LLC | 946,605 | $7,242,000 | 0.54% |
| Opaleye Management Inc. | 225,000 | $1,721,000 | 0.46% |
| Eventide Asset Management | 1,680,000 | $12,852,000 | 0.42% |